Bioflag

Bifidobacterium animalis subsp. lactis CP-9 is a product with benefits including fat reduction, antioxidant properties, stimulating the immune system, anti-aging effects, and improvements in urinary health. Labeling claims highlight that it is non-toxic, non-hazardous, and biodegradable. The production process involves fermentation, centrifuging, freeze-drying, and packaging. This product finds end uses in weight management products, dietary supplements, powdered beverages, and infant formula.

Bifidobacterium longum subsp. infantis BLI-02 is a product with benefits in blood glucose management, stimulating the immune system, antioxidant properties, and anti-aging effects. Labeling claims emphasize non-toxicity, non-hazardousness, and biodegradability. The production process includes fermentation, centrifuging, freeze-drying, and packaging. The end uses for this product are primarily dietary supplements.

Buidobacterium longum subsp. OLP-01 is a product clinically proven to enhance physical endurance and fitness and improve gut microbiota. This specific probiotic strain naturally originates from humans and is suitable for use in functional foods and dietary supplements in the form of capsules, tablets, powdered sachets, and others. The market for this product is in food and nutrition, with end uses in functional foods and nutraceuticals.

Lactobacillus fermentum TSF331 is a product with health benefit claims related to blood glucose management, antioxidant properties, anti-inflammatory effects, and promotion of lipid metabolism. Labeling claims highlight non-toxicity, non-hazardousness, and biodegradability. End uses for this product include dietary supplements, and the production process involves fermentation, centrifuging, freeze-drying, and packaging.

Lactobacillus paracasei MP137 is a product with health benefit claims that emphasize promoting healthy gut microflora and stimulating the immune system. Labeling claims highlight non-toxicity, non-hazardousness, and biodegradability. The product's primary end use is in dietary supplements, and it undergoes a production process that includes fermentation, centrifuging, freeze-drying, and packaging.

Lactobacillus plantarum LPL28 is a product whose strain origin is isolated from miso with no microbial domestication or mutation process. Applications for this product include oral care, pathogen inhibition, vaginal health, and GABA production. The production process involves fermentation, centrifuging, freeze-drying, and packaging.

Lactobacillus reuteri GL-104 is a product whose strain origin is isolated from healthy human intestines with no microbial domestication or mutation. Its applications include allergy relief, immunity regulation, oral care, and glucose control. The production process includes fermentation, centrifuging, freeze-drying, and packaging.

Lactobacillus rhamnosus MP108 is a product whose strain origin is isolated from healthy infants' intestines with no microbial domestication or mutation process. Its applications encompass intestine health, immune health, and oral health. Labeling claims highlight non-toxicity, non-hazardousness, and biodegradability. End uses include infant formula, dietary supplements, and functional foods.

Lactobacillus salivarius AP-32 is a product whose strain origin is isolated from healthy human intestines with no microbial domestication or mutation process. Applications span vaginal health, oral care, stomach care, gut health, blood glucose control, teeth whitening, weight management, and sleep support. The production process involves fermentation, centrifuging, freeze-drying, and packaging.

Lactobacillus paracasei ET-66 is a product whose strain origin is isolated from human breast milk with no microbial domestication or mutation process. Its applications include promoting oral health and upper gastrointestinal health. The production process involves fermentation, centrifuging, freeze-drying, and packaging. Health benefit claims for this product include promoting intestinal health, promoting oral health, and stimulating the immune system. Its end uses encompass dietary supplements.

Lactobacillus paracasei GL-156 is a product whose strain origin is isolated from healthy human intestines with no microbial domestication or mutation process. It is utilized for immunity strengthening, oral care, and skin whitening. The production process involves fermentation, centrifuging, freeze-drying, and packaging.

Lactobacillus rhamnosus bv-77 is a product whose strain origin is isolated from healthy human breast milk with no microbial domestication or mutation process. It is applied for the regulation of fat metabolism, gut health, pathogen inhibition, vaginal health, and as an antioxidant. The production process involves fermentation, centrifuging, freeze-drying, and packaging.

Lactobacillus rhamnosus F-1 is a product whose strain origin is isolated from healthy women's vaginas with no microbial domestication or mutation process. Applications include promoting vaginal health, anti-inflammation, oral care, and stomach health. The production process involves fermentation, centrifuging, freeze-drying, and packaging.

AR0301 presents a robust probiotic blend in powder form, tailored for pharma and nutraceutical use. Its distinct composition includes lactobacillus rhamnosus, limosilactobacillus reuteri, and lactobacillus paracasei, offering holistic support for digestive health and overall well-being. Carefully curated for a balanced microbial environment, this powder amplifies pharma and nutraceutical functions efficiently.

BE0301 is a probiotic product designed to support speedy recovery and combat fatigue. This specialized blend also enhances muscle strength and endurance. Tailored for pharmaceutical and nutraceutical purposes, it falls under the category of prebiotics, probiotics, and postbiotics, providing comprehensive health benefits.